TrialTargeted oncology2013

An analysis of the treatment effect of panitumumab on overall survival from a phase 3, randomized, controlled, multicenter trial (20020408) in patients with chemotherapy refractory metastatic colorectal cancer.

Melanie Poulin-Costello et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.